A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus
for Systemic Lupus Erythematosus
29 locations incl. Birmingham
Sponsor: UCB Biopharma SRL
Sex: All·Age: 16+
Code: NCT04976322·Phase 3·Enrolling By Invitation